The medical schemes industry reported a R20bn surplus in 2020 as members deferred treatment and lodged fewer claims during the coronavirus pandemic.

The unexpected cash pile, which was reported in the 2020/2021 report of the Council for Medical Schemes (CMS) tabled in parliament last week, enabled schemes to defer contribution increases or levy smaller-than-usual price hikes for 2021, offering relief to consumers who for the previous decade faced above-inflation annual contribution increases...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now